Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

CRISPR-edited DPSCs constitutively expressing BDNF enhance dentin regeneration in injured teeth.

Ji Hyun Kim | Muhammad Irfan | Sreelekshmi Sreekumar | Atsawasuwan Phimon | Stephanie Kim | Seung Chung
eLife | 2025

Dental caries, a prevalent global health issue, results from complex bacterial interactions. In response to harmful stimuli, a desirable outcome for the tooth is the formation of tertiary dentin, a protective reparative process that generates new hard tissue. This reparative dentinogenesis is associated with significant inflammation, which triggers the recruitment and differentiation of dental pulp stem cells (DPSCs). Previously, we have demonstrated that brain-derived neurotrophic factor (BDNF) and its receptor tropomyosin receptor kinase B (TrkB), key mediators of neural functions, are activated during the DPSC-mediated dentin regeneration process. In this study, we further define the role of inflammation in this process and apply stem cell engineering to enhance dentin regeneration in injured teeth. Our data show that TrkB expression and activation in DPSCs rapidly increase during odontogenic differentiation, further amplified by inflammatory inducers and mediators such as tumor necrosis factor alpha (TNFα), lymphotoxin-alpha, and lipopolysaccharide. An in vivo dentin formation assessment was conducted using a mouse pulp-capping/caries model, where Clustered Regularly Interspaced Short Palindromic Repeats-engineered DPSCs overexpressing BDNF were transplanted into inflamed pulp tissue. This transplantation significantly enhanced dentin regeneration in injured teeth. To further explore potential downstream pathways, we conducted transcriptomic profiling of TNFα-treated DPSCs, both with and without TrkB antagonist cyclotraxin-B. The results revealed significant changes in gene expression related to immune response, cytokine signaling, and extracellular matrix interactions. Taken together, our study advances our understanding of the role of BDNF in dental tissue engineering using DPSCs and identifies potential therapeutic avenues for improving dental tissue repair and regeneration strategies.

Pubmed ID: 40631557

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

Human TrkA Affinity Purified Polyclonal Ab (antibody)

RRID:AB_354970

This polyclonal targets Human TrkA Affinity Purified Ab

View all literature mentions

beta Actin Polyclonal Antibody (antibody)

RRID:AB_2539914

This unknown targets beta Actin

View all literature mentions

Phospho-TrkB (Tyr516) Polyclonal Antibody (antibody)

RRID:AB_2553666

This unknown targets Phospho-TrkB (Tyr516)

View all literature mentions

Purified anti-NTRK2 (antibody)

RRID:AB_2686965

This monoclonal targets NTRK2

View all literature mentions

GFP Antibody (FL) (antibody)

RRID:AB_641123

This polyclonal targets GFP

View all literature mentions

beta Tubulin Loading Control Monoclonal Antibody (BT7R) (antibody)

RRID:AB_2537819

This monoclonal targets beta Tubulin Loading Control

View all literature mentions

GluR-3 (C-20) (antibody)

RRID:AB_2113895

This polyclonal targets GluR-3 (C-20)

View all literature mentions

B10.D2-Hc0 H2 H2-T18/oSnJ (organism)

RRID:IMSR_JAX:000461

Mus musculus with name B10.D2-Hc0 H2 H2-T18/oSnJ from IMSR.

View all literature mentions